Relay Therapeutics Inc.

NASDAQ: RLAY · Real-Time Price · USD
3.54
0.15 (4.42%)
At close: Aug 15, 2025, 3:59 PM
3.60
1.80%
After-hours: Aug 15, 2025, 07:53 PM EDT

Relay Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-311.55M -333.39M -337.71M -345.2M -322.83M -329.12M -341.97M -325.98M -344.42M -322.7M -290.51M -290.46M -267.12M -383.73M -363.87M -261.14M -236.38M -69.71M
Depreciation & Amortization
-8.21M -6.45M -4.67M -4.63M 5.5M 5.47M 5.27M 5.06M 4.73M 4.35M 4.13M 4M 3.98M 3.98M 3.92M 3.8M 3.7M 3.61M
Stock-Based Compensation
73.94M 86.28M 94.14M 95.77M 95.12M 91.7M 86.03M 80.58M 72.47M 64.2M 56.14M 52.54M 51.24M 52.24M 48.45M 52.78M 52.29M 40.18M
Other Working Capital
-38.92M -28.33M -16.36M -43.68M -26.8M -36.03M -30.37M 11.23M 5.86M 5.4M 2.85M -1.57M 3.48M 3.59M 277K 531K -2.68M 74K
Other Non-Cash Items
20.76M 3.18M -2.32M -10.85M -32.17M -19.66M -17.18M -17.3M -12.5M -10.15M -11.04M 724K -878K 134.33M 138.39M 137.57M 135.58M 58K
Deferred Income Tax
n/a n/a n/a 5.08M 2.2M n/a n/a -5.08M -2.2M n/a n/a 681K 1.35M 1.35M 1.35M 669K -1K n/a
Change in Working Capital
-36.36M -21.61M 1.45M -20.6M -28.56M -31.89M -32.46M -5.49M 22.97M 16.3M 11.25M 19.86M 11.72M 21.62M 97.34M -3.65M 4M -7.65M
Operating Cash Flow
-261.42M -271.99M -249.11M -280.43M -280.74M -283.51M -300.32M -268.21M -258.95M -247.45M -229.49M -212.12M -199.17M -170.22M -74.41M -69.97M -40.81M -33.52M
Capital Expenditures
-637K -622K -2.02M -2.14M -2.5M -3.99M -4.13M -6.32M -7.83M -8.18M -9.06M -7.63M -7.27M -5.79M -3.47M -2.65M -1.35M -1.39M
Cash Acquisitions
n/a n/a n/a -257.63M -329.59M -382.37M -459.6M -57.34M -14.67M 38.11M 115.34M -29.36M -166K -25.3M -25.3M -25.21M -25.13M n/a
Purchase of Investments
-371.11M -481.82M -650.63M -712.37M -531.99M -478.51M -385.54M -576.37M -547.45M -505.54M -535.42M -534.81M -486.37M -489.04M -980.66M -779.99M -841.59M -830.17M
Sales Maturities Of Investments
392.19M 473.29M 611.56M 704.1M 721.61M 675.35M 647.3M 633.71M 562.12M 512.68M 355.74M 207.97M 152.85M 161.85M 529.92M 544.67M 604.17M 629.23M
Other Investing Acitivies
n/a n/a n/a 257.63M 329.59M 382.37M 459.6M 57.34M 14.67M 7.14M -179.68M -326.85M -333.52M -403.9M -527.45M -312.03M -314.13M -200.93M
Investing Cash Flow
20.45M -9.15M -41.08M -10.4M 187.12M 192.85M 257.63M 51.02M 6.84M -1.05M -188.75M -334.55M -340.95M -358.27M -479.51M -263.19M -263.9M -202.32M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
653K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.45M -2.45M -2.45M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
267.42M 267.42M 268.61M 2.92M 2.28M 4.36M 4.47M 4.64M 290.41M 290.32M 289.91M 290.55M 4.68M 2.69M 1.8M 56K -1.99M -2.45M
Financial Cash Flow
220.34M 221.23M 270.15M 291.27M 81.84M 82.38M 34.75M 14M 290.41M 290.32M 289.91M 672.76M 387.79M 386.92M 388.09M 4.13M 429.43M 428.21M
Net Cash Flow
-20.63M -59.91M -20.04M 441K -11.78M -8.28M -7.93M -203.19M 38.3M 41.83M -128.32M 126.08M -152.33M -141.57M -165.83M -329.02M 124.72M 192.38M
Free Cash Flow
-262.06M -272.62M -251.13M -282.56M -283.24M -287.5M -304.44M -274.53M -266.78M -255.63M -238.55M -219.74M -206.44M -176.01M -77.88M -72.63M -42.16M -34.9M